Extendicare Inc faced a setback in its stock performance following a strong earnings report.
Extendicare Inc's stock price fell by 2.43% in yesterday's trading session, closing at CA$31.71. This decline comes despite the company reporting impressive second-quarter results that showcased significant revenue growth and strong operational performance.
Advertisement
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeAdvertisement
Market cap
$3.09B
P/E
23.9x
Div. yield
1.58%
Div. / share
$0.51
52W high
$39.09
52W low
$12.39
1W change
-8.11%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 24.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$39.61
+24.9% Upside
Current Price
C$31.71
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
32.8%
Annualized
90-Day Vol
35.3%
Annualized
Trend (90d)
-18.4%
Annualized drift
90d Mean
C$29.69
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$31.02 | C$27.71 – C$34.74 |
| 60 trading days | C$30.35 | C$25.87 – C$35.61 |
| 90 trading days | C$29.69 | C$24.41 – C$36.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: While Extendicare's recent acquisitions have bolstered its revenue, the market's reaction suggests that investors remain cautious about the integration challenges and potential impacts on margins.
Revenue Surge vs. Stock Decline
Advertisement
Despite a 59.4% increase in revenue to C$611 million, Extendicare's stock fell, indicating a disconnect between operational success and market sentiment.
Bull case
Extendicare's strong Q2 growth, with a 59.4% increase in revenue, shows that the company is executing well operationally. This growth suggests there is potential for future profitability as they work through the integration of their acquisitions.
Bear case
The stock's decline highlights investor concerns about how well Extendicare will integrate its recent acquisitions. There are worries that this process could strain profit margins due to increased operational costs.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
